Pharmacielo Ltd
XTSX:PCLO
Pharmacielo Ltd
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The Company’s principal subsidiary includes PharmaCielo Colombia Holdings S.A.S. The company produces non-psychoactive and psychoactive extracts. Its psychoactive product line is designed and formulated to meet the needs of the medical industry. Its psychoactive products include THC Distillate and THC:CBD Standardized Oil. Its non-psychoactive products are designed to meet the needs of clients in the medical, nutraceutical and wellness industries. Its non-psychoactive products include Broad-Spectrum Distillate Standardized Oil, CBD Isolate, Broad-Spectrum Distillate, Broad-Spectrum Oil, Water-Soluble CBD, CBD Standardized Oil and Full-Spectrum Standardized Oil.
PharmaCielo Ltd. operates as a pharmaceutical company. The company is headquartered in Toronto, Ontario. The company went IPO on 2018-01-30. The Company’s principal subsidiary includes PharmaCielo Colombia Holdings S.A.S. The company produces non-psychoactive and psychoactive extracts. Its psychoactive product line is designed and formulated to meet the needs of the medical industry. Its psychoactive products include THC Distillate and THC:CBD Standardized Oil. Its non-psychoactive products are designed to meet the needs of clients in the medical, nutraceutical and wellness industries. Its non-psychoactive products include Broad-Spectrum Distillate Standardized Oil, CBD Isolate, Broad-Spectrum Distillate, Broad-Spectrum Oil, Water-Soluble CBD, CBD Standardized Oil and Full-Spectrum Standardized Oil.